{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:23:26Z","timestamp":1776356606200,"version":"3.51.2"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141002"],"award-info":[{"award-number":["32141002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302574"],"award-info":[{"award-number":["82302574"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172311"],"award-info":[{"award-number":["82172311"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["LHGJ20210594"],"award-info":[{"award-number":["LHGJ20210594"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijantimicag.2025.107642","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:20:27Z","timestamp":1759990827000},"page":"107642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular characterisation of two novel KPC variants mediating ceftazidime-avibactam resistance in ST11 Klebsiella pneumoniae"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2580-4286","authenticated-orcid":false,"given":"Tengfei","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siquan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6730-180X","authenticated-orcid":false,"given":"Chengkang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-0619","authenticated-orcid":false,"given":"Fupin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107642_bib0001","first-page":"1","article-title":"Antibiotic resistance: a global crisis, problems and solutions","author":"Aggarwal","year":"2024","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0002","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","article-title":"Molecular and clinical epidemiology of carbapenem-resistant enterobacterales in the USA (CRACKLE-2): a prospective cohort study","volume":"20","author":"van Duin","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101031","article-title":"Global distribution and genomic characteristics of carbapenemase-producing Escherichia coli among humans, 2005-2023","volume":"72","author":"Li","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0005","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0006","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tim.2014.09.003","article-title":"Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding","volume":"22","author":"Chen","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101083","article-title":"Expansion and transmission dynamics of high risk carbapenem-resistant Klebsiella pneumoniae subclones in China: an epidemiological, spatial, genomic analysis","volume":"74","author":"Wang","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02349-16","article-title":"Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States","volume":"61","author":"Satlin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0009","article-title":"How to manage KPC infections","volume":"7","author":"Bassetti","year":"2020","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0010","doi-asserted-by":"crossref","first-page":"i47","DOI":"10.1093\/jac\/dkaa497","article-title":"Role of new antibiotics for KPC-producing Klebsiella pneumoniae","volume":"76","author":"Theuretzbacher","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02431-18","article-title":"Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the in vitro activities of ceftazidime-avibactam and ceftolozane-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa","volume":"63","author":"Yin","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0012","doi-asserted-by":"crossref","first-page":"e00008","DOI":"10.1128\/cmr.00008-23","article-title":"Klebsiella pneumoniae carbapenemase variants: the new threat to global public health","volume":"36","author":"Ding","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0013","doi-asserted-by":"crossref","first-page":"e1571","DOI":"10.1002\/wsbm.1571","article-title":"Molecular mechanisms underlying bacterial resistance to ceftazidime\/avibactam","volume":"14","author":"Xiong","year":"2022","journal-title":"WIREs Mech Dis"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0014","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/cid\/ciaa1521","article-title":"Emergence and recovery of ceftazidime-avibactam resistance in blaKPC-33-harboring Klebsiella pneumoniae sequence type 11 isolates in China","volume":"71","author":"Shi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00725-23","article-title":"Emergence of KPC-134, a KPC-2 variant associated with ceftazidime-avibactam resistance in a ST11 Klebsiella pneumoniae clinical strain","volume":"11","author":"Huang","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00487-22","article-title":"Identification of KPC-112 from an ST15 Klebsiella pneumoniae strain conferring resistance to ceftazidime-avibactam","volume":"7","author":"Shen","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00859-21","article-title":"Molecular mechanisms driving the in vivo development of KPC-71-mediated resistance to ceftazidime-avibactam during treatment of carbapenem-resistant Klebsiella pneumoniae infections","volume":"6","author":"Li","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0018","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2361007","article-title":"Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae","volume":"13","author":"Shi","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00447-22","article-title":"Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-avibactam: an evolutionary overview","volume":"66","author":"Hobson","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0020","series-title":"CLSI supplement M100","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2024"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0021","unstructured":"FDA-recognized antimicrobial susceptibility test interpretive criteria: U.S. Food and Drug Administration; 2023. https:\/\/www.fda.gov\/drugs\/development-resources\/tigecycline-injection-products"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0022","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0, 2025. https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.609856","article-title":"Evaluation of the immunochromatographic NG-Test Carba 5, RESIST-5 O.O.K.N.V., and IMP K-SeT for rapid detection of KPC-, NDM-, IMP-, VIM-type, and OXA-48-like carbapenemase among enterobacterales","volume":"11","author":"Han","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0024","doi-asserted-by":"crossref","first-page":"8365","DOI":"10.1038\/srep08365","article-title":"RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes","volume":"5","author":"Brettin","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0025","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/JCM.06094-11","article-title":"Multilocus sequence typing of total-genome-sequenced bacteria","volume":"50","author":"Larsen","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0026","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/jac\/dkaa345","article-title":"ResFinder 4.0 for predictions of phenotypes from genotypes","volume":"75","author":"Bortolaia","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104984","article-title":"Solving the problem of comparing whole bacterial genomes across different sequencing platforms","volume":"9","author":"Kaas","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0028","doi-asserted-by":"crossref","first-page":"W484","DOI":"10.1093\/nar\/gkad326","article-title":"Proksee: in-depth characterization and visualization of bacterial genomes","volume":"51","author":"Grant","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0029","doi-asserted-by":"crossref","first-page":"W768","DOI":"10.1093\/nar\/gkac321","article-title":"VRprofile2: detection of antibiotic resistance-associated mobilome in bacterial pathogens","volume":"50","author":"Wang","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/22221751.2021.2013105","article-title":"Replicative transposition contributes to the evolution and dissemination of KPC-2-producing plasmid in enterobacterales","volume":"11","author":"Tang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127893","article-title":"KPC variants conferring resistance to ceftazidime-avibactam in Pseudomonas aeruginosa strains","volume":"289","author":"Hu","year":"2024","journal-title":"Microbiol Res"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0032","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00150-21","article-title":"Characterization of KPC-82, a KPC-2 variant conferring resistance to ceftazidime-avibactam in a carbapenem-nonsusceptible clinical isolate of Citrobacter koseri","volume":"65","author":"Lebreton","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0033","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/pathogens10010067","article-title":"Emergence of the new KPC-49 variant conferring an ESBL phenotype with resistance to ceftazidime-avibactam in the ST131-H30R1 Escherichia coli high-risk clone","volume":"10","author":"Hern\u00e1ndez-Garc\u00eda","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107149","article-title":"Spread and evolution of blaKPC-plasmid between Serratia marcescens and Klebsiella pneumoniae","volume":"63","author":"Yang","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107163","article-title":"Emergence of ceftazidime-avibactam resistance in blaKPC-33-harboring ST11 Klebsiella pneumoniae in pediatric patient","author":"Zhou","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0036","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/jac\/dkv356","article-title":"Lateral dissemination and inter-patient transmission of blaKPC-3: role of a conjugative plasmid in spreading carbapenem resistance","volume":"71","author":"Tijet","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0037","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fmicb.2018.00056","article-title":"Klebsiella pneumoniae carbapenemase producers in South Korea between 2013 and 2015","volume":"9","author":"Yoon","year":"2018","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107642_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02244-19","article-title":"Genomic epidemiology of complex, multispecies, plasmid-borne blaKPC carbapenemase in enterobacterales in the United Kingdom from 2009 to 2014","volume":"64","author":"Stoesser","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107642_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00194-21","article-title":"Genomic features associated with the degree of phenotypic resistance to carbapenems in carbapenem-resistant Klebsiella pneumoniae","volume":"6","author":"Bulman","year":"2021","journal-title":"mSystems"},{"issue":"3","key":"10.1016\/j.ijantimicag.2025.107642_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.10.013","article-title":"A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate","volume":"29","author":"Yang","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0041","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/microorganisms12061193","article-title":"Identification of a novel KPC variant, KPC-204, conferring resistance to both Carbapenems and ceftazidime-avibactam in an ST11 Klebsiella pneumoniae strain","volume":"12","author":"Gong","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01936-19","article-title":"Potency of vaborbactam is less affected than that of avibactam in strains producing KPC-2 mutations that confer resistance to ceftazidime-avibactam","volume":"64","author":"Tsivkovski","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0043","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2147\/IDR.S406319","article-title":"Phenotypic and genetic analysis of KPC-49, a KPC-2 variant conferring resistance to ceftazidime-avibactam and maintaining resistance to imipenem and meropenem","volume":"16","author":"Yu","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"8","key":"10.1016\/j.ijantimicag.2025.107642_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.04.016","article-title":"Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC \u03b2-lactamase mutants and the inoculum effect","volume":"27","author":"Hobson","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107642_bib0045","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jac\/dkaf048","article-title":"High-level cefiderocol and ceftazidime\/avibactam resistance in KPC-producing Klebsiella pneumoniae associated with mutations in KPC and the sensor histidine kinase EnvZ","volume":"80","author":"Findlay","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00154-24","article-title":"Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae blaKPC-2 variants","volume":"62","author":"Zhang","year":"2024","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0047","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00954-21","article-title":"Comparison of four carbapenemase detection methods for blaKPC-2 variants","volume":"9","author":"Ding","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0048","article-title":"KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97","volume":"12","author":"Sanz","year":"2024"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107642_bib0049","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02776-23","article-title":"Evolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1-Escherichia coli isolates with KPC-3 mutants and application of FTIR biotyping","volume":"12","author":"Castillo-Polo","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0050","doi-asserted-by":"crossref","first-page":"ofab141","DOI":"10.1093\/ofid\/ofab141","article-title":"Meropenem-vaborbactam as salvage therapy for ceftazidime-avibactam-, cefiderocol-resistant ST-512 Klebsiella pneumoniae-producing KPC-31, a D179Y variant of KPC-3","volume":"8","author":"Tiseo","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0051","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/antibiotics11050604","article-title":"Ceftazidime-avibactam in combination with imipenem as salvage therapy for ST11 KPC-33-producing Klebsiella pneumoniae","volume":"11","author":"Ding","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107642_bib0052","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jgar.2023.03.012","article-title":"Ceftazidime\/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations","volume":"33","author":"Oliva","year":"2023","journal-title":"J Glob Antimicrob Resist"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:09:00Z","timestamp":1775516940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925001979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0924857925001979"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107642","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterisation of two novel KPC variants mediating ceftazidime-avibactam resistance in ST11 Klebsiella pneumoniae","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107642"}}